A multisystem investigation of raltegravir association with intestinal tissue: implications for pre-exposure prophylaxis and eradication
Author(s) -
Darren Moss,
Paul Curley,
Allison E. Shone,
Marco Siccardi,
Andrew Owen
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku312
Subject(s) - raltegravir , in vivo , ex vivo , pharmacology , small intestine , pharmacokinetics , in silico , biology , chemistry , biochemistry , immunology , microbiology and biotechnology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , gene
Recent clinical data have suggested high raltegravir concentrations in gut tissue after oral administration, with implications for treatment and prevention. We have used in silico, in vitro, ex vivo and in vivo models to further investigate the accumulation of raltegravir in gut tissue.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom